{"abstract":"Quagen Pharmaceuticals LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.","action":"Notice of application.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/04/17/2026-07559.html","cfr_references":[],"citation":"91 FR 20702","comment_url":null,"comments_close_on":"2026-05-18","correction_of":null,"corrections":[],"dates":"Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 18, 2026. Such persons may also file a written request for a hearing on the application on or before May 18, 2026.","disposition_notes":null,"docket_ids":["Docket No. DEA-1701"],"dockets":[],"document_number":"2026-07559","effective_on":null,"end_page":20703,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/04/17/2026-07559.xml","html_url":"https://www.federalregister.gov/documents/2026/04/17/2026-07559/importer-of-controlled-substances-application-quagen-pharmaceuticals-llc","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-07559?publication_date=2026-04-17","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-04-17/2026-07559/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":22,"last_updated":"2026-04-17 12:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-17/pdf/2026-07559.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-07559.pdf?1776343520","publication_date":"2026-04-17","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/04/17/2026-07559.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2026-04-17T05:04:47Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":20702,"subtype":null,"title":"Importer of Controlled Substances Application: Quagen Pharmaceuticals LLC","toc_doc":"Quagen Pharmaceuticals LLC","toc_subject":"Importer, Manufacturer or Bulk Manufacturer of Controlled Substances; Application, Registration, etc.","topics":[],"type":"Notice","volume":91}